Big 12 Announces Antigen Testing Partnership with Goodside Health

Click here for the original story on Big 12 Sports

AUSTIN, Texas — The Big 12 Conference today announced an antigen testing partnership with Goodside Health. Big 12 football programs will utilize Goodside Health to facilitate COVID-19 day-prior-to-competition testing for players, coaches and support personnel. The testing program will utilize Quidel Rapid Antigen tests which allows for 15-minute results and batch testing capabilities.

“Partnering with [Goodside Health] provides a turn-key solution to antigen testing and ensures consistent, Conference-wide protocols,” said Big 12 Executive Associate Commissioner Edward Stewart.

“We are excited to partner with the Big 12 on this testing program,” commented Goodside Health CEO Brian White, “and applaud the Conference in taking this important step to bring back college sports while staying supremely focused on the health and safety of its student-athletes.”

As part of its testing protocols Big 12 football programs are required to test for COVID-19 three times per week, with each program facilitating providers for the additional weekly tests.

About Goodside Health

Goodside Health is advancing the delivery of pediatric care by partnering with communities to provide access to telehealth, mental health, and well-care services at school, at home, and in the clinic. Relentless advocates for expanding access to care and promoting health equity, Goodside Health leverages a Whole-Child Approach to care and lives our mission of closing gaps in children’s healthcare through innovation and execution. To learn more about Goodside Health, please visit